Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Retired Pharmacist, and Founder of Prevail Over Cancer
Flashier nutrients in discussions about cancer often overshadow magnesium, yet it plays a foundational role in cellular health, immune regulation, and metabolic balance. Emerging research reveals that magnesium deficiency may not only increase cancer risk but also impair recovery, worsen treatment side effects, and disrupt quality of life. Let’s explore the science behind magnesium’s anticancer benefits—and why it deserves a central place in integrative oncology.
Magnesium is a cofactor in over 600 enzymatic reactions, including DNA repair, RNA synthesis, and ATP production. It regulates oxidative stress, inflammation, and calcium signaling—all of which are tightly linked to cancer development and progression.
Multiple studies have identified specific cancers with elevated risk due to low magnesium intake or serum levels:
Cancer Type |
Evidence Summary |
Colorectal Cancer |
Higher magnesium intake linked to 21–41% lower risk in cohort studies |
Pancreatic Cancer |
Intake below 75% RDA associated with 76% higher risk |
Breast Cancer |
TRPM7 channel dysregulation linked to tumor aggressiveness |
Prostate Cancer |
Magnesium deficiency may impair DNA repair and immune surveillance |
Lymphoma |
Animal studies show thymic atrophy and immune dysfunction under deficiency |
Glioblastoma |
Magnesium transporters influence ECM remodeling and tumor expansion |
Learn How to Select a Quality Dietary Supplement
Emerging research suggests magnesium influences the gut microbiome, enhancing bacteria populations that convert precursors into active vitamin D, a known anti-carcinogenic agent in colorectal tissue. This nutrient–microbiota synergy could be a game-changer in integrative oncology.
Vitamin D-synthesizing bacteria, such as Lactobacillus and Bifidobacterium, thrive in magnesium-rich environments, which in turn decrease inflammation, Wnt signaling, and improve epithelial intestinal lining integrity—all key factors in colorectal cancer prevention.
Magnesium isn’t just a mineral—it’s a microbiome modulator with anti-cancer potential. Integrative strategies that pair magnesium with microbiota-supportive diets may enhance vitamin D signaling and reduce the risk of carcinogenesis.
While direct studies are still evolving, this is worth monitoring.
Beyond prevention, magnesium helps manage common symptoms and side effects during treatment:
🧠 Pain Management
💩 Constipation
😰 Anxiety & Sleep
⚡ Energy & Fatigue
🍬 Blood Glucose Control
Among the many forms available, magnesium glycinate is my preferred choice. It’s:
For patients undergoing cancer treatment, this form offers a well-tolerated option that supports both physical and emotional resilience.
My wife, Janay, and I take either one of the following magnesium glycinate twice a day:
📚 Magnesium and Cancer Reference Sources
[i] Sambataro D, Scandurra G, Scarpello L, Gebbia V, Dominguez LJ, Valerio MR. A Practical Narrative Review on the Role of Magnesium in Cancer Therapy. Nutrients. 2025; 17(14):2272. https://doi.org/10.3390/nu17142272
Sun, E., Zhu, X., Ness, R., Murff, H. J., Sun, S., Yu, C., Fan, L., Azcarate-Peril, M., Shrubsole, M. J., & Dai, Q. (2025). Magnesium Treatment Increases Gut Microbiome Synthesizing Vitamin D and Inhibiting Colorectal Cancer: Results from a Double-Blind Precision-based Randomized Placebo-Controlled Trial. The American Journal of Clinical Nutrition. https://doi.org/10.1016/j.ajcnut.2025.09.011
Wesselink, E., Kok, D. E., Bours, M. J., De Wilt, J. H., Van Baar, H., Van Zutphen, M., Geijsen, A. M., Keulen, E. T., Hansson, B. M., Van den Ouweland, J., Witkamp, R. F., Weijenberg, M. P., Kampman, E., & Van Duijnhoven, F. J. (2020). Vitamin D, magnesium, calcium, and their interaction in relation to colorectal cancer recurrence and all-cause mortality. The American Journal of Clinical Nutrition, 111(5), 1007-1017. https://doi.org/10.1093/ajcn/nqaa049